Cryptococcosis with disseminated disease has emerged as a primary cause of opportunistic infections associated with Acquired Immunodeficiency Syndrome (AIDS). Pneumocystis carinii (pneumonia), Cryptococcus neoformans (cryptococcosis), Toxoplasma gondii (toxoplasmosis), Mycobacterium avium-M. intercellular occur as opportunistic infections in 50-70% of AIDS patients. Approximately 10% of AIDS patients have cryptococcosis. Although the yeast can affect any organ, it has a predilection for the central nervous system, where it causes cryptococcal meningoencephalitis. If gone untreated this disease is fatal and is the cause of death in one of five AIDS patients. In the pre-AIDS era both varieties of C. Neoforman (C. neoformans var. neoformans and C. neoformans var. gattii) were isolated from clinical specimens whereas today c. neoformans isolates from AIDS patients are almost invariably of the neoformans variety. There appears to be a selective infection of AIDS patients with the neoformans variety and 99% of these are of the A serotype. The capsular polysaccharide injures certain aspects of the immune system; inhibition of phagocytosis, depletion of complement, and induction of suppressor T-cell networks. In a recent report the capsular polysaccharide was shown to enhance HIV-1 infectivity in H9 cells. It has also been demonstrated that other cell envelope antigens may play a role in the enhancement of HIV-1 replication in T-cells. The research from this laboratory emphasizes the characterization of C. neoformans at the molecular level, capsule structure and sequence, other cell envelope antigens, cell wall glucans, and epitope structure. Exact chemical sequences present in glucuronoxylomannan (GXM) of C. neoformans are being determined by using advanced methods in nuclear magnetic resonance spectroscopy. Epitope specificity of monoclonal antibodies, Factor sera, and polyclonal rabbit sera-fractionated by tandem-column affinity chromatography with purified GXMs serving as the immobilized ligand-are being determined. The isolated, purified, and characterized antigens are useful in the study of the mechanisms by which C. neoformans effects the immune system in normal or immunocompromised hosts (AIDS), in culture, and in animal models.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI031769-04
Application #
2066696
Study Section
AIDS and Related Research Study Section 5 (ARRE)
Project Start
1991-07-01
Project End
1997-01-31
Budget Start
1994-07-01
Budget End
1995-01-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Georgia State University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
837322494
City
Atlanta
State
GA
Country
United States
Zip Code
30302
Goins, T L; Cutler, J E (2000) Relative abundance of oligosaccharides in Candida species as determined by fluorophore-assisted carbohydrate electrophoresis. J Clin Microbiol 38:2862-9
Cherniak, R; O'Neill, E B; Sheng, S (1998) Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy. Infect Immun 66:2996-8
Vaishnav, V V; Bacon, B E; O'Neill, M et al. (1998) Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 306:315-30
Franzot, S P; Mukherjee, J; Cherniak, R et al. (1998) Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66:89-97
Cherniak, R; Valafar, H; Morris, L C et al. (1998) Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5:146-59
Belay, T; Cherniak, R; Kozel, T R et al. (1997) Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun 65:718-28
Han, Y; Kanbe, T; Cherniak, R et al. (1997) Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun 65:4100-7
Belay, T; Cherniak, R; O'Neill, E B et al. (1996) Serotyping of Cryptococcus neoformans by dot enzyme assay. J Clin Microbiol 34:466-70
Bacon, B E; Cherniak, R; Kwon-Chung, K J et al. (1996) Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy. Carbohydr Res 283:95-110
Cherniak, R; Morris, L C; Belay, T et al. (1995) Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun 63:1899-905

Showing the most recent 10 out of 19 publications